The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The IRX-2 regimen combined with nivolumab in recurrent/metastatic solid tumors: A phase 1b study to evaluate the safety, determine recommended phase 2 dose (RP2D), and investigate the biologic and clinical activity.
 
Rohit K. Jain
No Relationships to Disclose
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Sanofi
Speakers' Bureau - AstraZeneca/MedImmune; Sanofi
Research Funding - Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst)
 
Zeynep Eroglu
Consulting or Advisory Role - Array BioPharma; Compugen; Regeneron
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Tesaro
 
Ben C. Creelan
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Andrew Scott Brohl
Expert Testimony - GlaxoSmithKline (I)
 
Michael Rahman Shafique
No Relationships to Disclose
 
Jhanelle Elaine Gray
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genentech/Roche; Janssen; Lilly
Speakers' Bureau - Genentech
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Epic Sciences (Inst); Genentech/Roche (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Genentech/Roche; Janssen Oncology
 
Jameel Muzaffar
No Relationships to Disclose
 
Julia Ida
No Relationships to Disclose
 
Mensura Lacevic
No Relationships to Disclose
 
Youngchul Kim
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; CUE Biopharma; Ignyta
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ignyta; IRX Therapeutics; Lilly; Lion Biotechnologies; Merck; Pfizer; Regeneron
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Solmaz Sahebjam
Honoraria - Bristol-Myers Squibb; Merck Serono
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb (Inst); Cortice Bioscience (Inst); Merck Serono (Inst)